Lumos Pharma Inc (NAS:LUMO)
$ 4.38 0.08 (1.86%) Market Cap: 37.88 Mil Enterprise Value: 23.84 Mil PE Ratio: 0 PB Ratio: 7.68 GF Score: 48/100

NewLink Genetics Corp and Lumos Pharma Inc Enters Into A Definitive Merger Agreement - Conference Call Transcript

Oct 01, 2019 / 12:30PM GMT
Release Date Price: $11.16 (-22.01%)
Operator

Good morning, ladies and gentlemen, and welcome to the NewLink Genetics and Lumos Pharma Merger Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now turn the call over to Lisa Miller, Director of Investor Relations at NewLink Genetics. You may begin, ma'am.

Lisa Miller
NewLink Genetics Corporation - Director of IR

Thank you. I would like to remind everyone that certain statements made during this call are forward-looking statements under U.S. Federal securities law. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information concerning factors that could cause actual results to differ is contained in our periodic reports filed with the SEC. The forward-looking statements made during this call speak only as of the date hereof, and the company undertakes no obligation to update or revise the forward-looking statements. Information presented on this call is contained in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot